LLY

723.52

-0.17%↓

JNJ

180.91

+0.71%↑

ABBV

220.83

+0.05%↑

UNH

343.05

-0.32%↓

NVO

55.34

-0.47%↓

LLY

723.52

-0.17%↓

JNJ

180.91

+0.71%↑

ABBV

220.83

+0.05%↑

UNH

343.05

-0.32%↓

NVO

55.34

-0.47%↓

LLY

723.52

-0.17%↓

JNJ

180.91

+0.71%↑

ABBV

220.83

+0.05%↑

UNH

343.05

-0.32%↓

NVO

55.34

-0.47%↓

LLY

723.52

-0.17%↓

JNJ

180.91

+0.71%↑

ABBV

220.83

+0.05%↑

UNH

343.05

-0.32%↓

NVO

55.34

-0.47%↓

LLY

723.52

-0.17%↓

JNJ

180.91

+0.71%↑

ABBV

220.83

+0.05%↑

UNH

343.05

-0.32%↓

NVO

55.34

-0.47%↓

Kodu・Aktsiate loetelu・Savara Inc

Savara Inc

Avatud

SektorTervishoid

3.55 1.14

Osta Müü

Ülevaade

Aktsiahinna muutus

24h

Praegune

Min

3.49

Max

3.58

Põhinäitajad
By Trading Economics
Sissetulek	-3.8M -30M
Kasumimarginaal	-10,677.941
Töötajad	59
EBITDA	-1.9M -30M

Soovitused
By TipRanks
Soovitused	Tugev "osta" hinnang
12 kuu keskmine prognoos	+150.85% upside

Dividendid
By Dow Jones
Järgmine tulemuste avaldamine	11. nov 2025

Turustatistika
By TradingEconomics
Turukapital	137M 603M
Eelmine avamishind	2.41
Eelmine sulgemishind	3.55

Uudiste sentiment

By Acuity

83%

17%

347 / 371 Pingereas Healthcare

Tehniline skoor

By Trading Central

Kindlus

Neutral Evidence

2.76 / 2.84 Toetus ja vastupanu

Savara Inc Graafik

Mineviku tootlus ei ole usaldusväärne näitaja tulevaste tulemuste kohta.

Seotud uudised

26. sept 2025, 18:25 UTC

Suurimad hinnamuutused turgudel

Mirion Technologies Stock Rises on Expanded Notes, Shares Offerings

28. sept 2025, 23:48 UTC

Market Talk

Nikkei May Rise After Friday's Stock Gains on Wall Street -- Market Talk

28. sept 2025, 23:48 UTC

Market Talk

Global Equities Roundup: Market Talk

28. sept 2025, 23:45 UTC

Market Talk

Gold Rises Amid Fed Rate-Cut Hopes -- Market Talk

28. sept 2025, 23:34 UTC

Market Talk

Oil Falls on Likely Technical Correction -- Market Talk

27. sept 2025, 04:15 UTC

Market Talk

Global Commodities Roundup: Market Talk

26. sept 2025, 21:56 UTC

Omandamised, ülevõtmised, äriostud

Staar Surgical, Insight Enterprises, and More Stocks See Action From Activist Investors -- Barrons.com

26. sept 2025, 20:54 UTC

Tulu

U.S. TikTok for $14 Billion? Making Sense of the Bargain-Basement Price. -- Barrons.com

26. sept 2025, 20:50 UTC

Market Talk

Tech, Media & Telecom Roundup: Market Talk

26. sept 2025, 20:50 UTC

Market Talk

Basic Materials Roundup: Market Talk

26. sept 2025, 20:27 UTC

Omandamised, ülevõtmised, äriostud

Electronic Arts Stock Pops on Report Videogame Maker Is Close to Going Private -- Barrons.com

26. sept 2025, 20:15 UTC

Market Talk

Global Commodities Roundup: Market Talk

26. sept 2025, 19:54 UTC

Market Talk

Canada's Can't-Build Reputation Is Somewhat Earned -- Market Talk

26. sept 2025, 19:53 UTC

Omandamised, ülevõtmised, äriostud

Electronic Arts Stock Pops on Report Videogame Maker Is Close to Going Private -- Barrons.com

26. sept 2025, 19:40 UTC

Tulu

The U.S. TikTok Is Apparently Fetching a Bargain-Basement Price. A Few Reasons Why. -- Barrons.com

26. sept 2025, 19:24 UTC

Market Talk

U.S. Natural Gas Futures Mixed As October Expires -- Market Talk

26. sept 2025, 19:17 UTC

Market Talk

Oil Posts Weekly Gains on Russia-Ukraine Tensions -- Market Talk

26. sept 2025, 19:15 UTC

Market Talk

AI Deployment Beginning to Weigh on Job Creation, Former Central Banker Says -- Market Talk

26. sept 2025, 19:03 UTC

Market Talk

Global Equities Roundup: Market Talk

26. sept 2025, 19:03 UTC

Market Talk

Gold Fuels Stellar Performance in Toronto Stock Market -- Market Talk

26. sept 2025, 18:50 UTC

Market Talk

Tulu

Costco's Executive Membership Gains Seen as Offsetting Slower Renewal Rates -- Market Talk

26. sept 2025, 18:36 UTC

Market Talk

Silver Closes Out Week With Strong Surge -- Market Talk

26. sept 2025, 18:02 UTC

Omandamised, ülevõtmised, äriostud

ING: Continue Working Towards Completing Transaction, Exit From Russian Market >ING

26. sept 2025, 18:02 UTC

Omandamised, ülevõtmised, äriostud

ING: Global Development Hasn't Received All Necessary Approvals >ING

26. sept 2025, 18:02 UTC

Omandamised, ülevõtmised, äriostud

ING: No Realistic Prospect of Completing Sale of ING Bank (Eurasia) to Global Development in 3Q

26. sept 2025, 17:54 UTC

Market Talk

U.S. Oil Rig Count Rises For Fifth Straight Week -- Market Talk

26. sept 2025, 16:56 UTC

Market Talk

Tulu

Costco Increasingly Challenged to Meet Lofty Expectations -- Market Talk

26. sept 2025, 16:41 UTC

Market Talk

Tulu

Costco's Valuation Seen as Too High Amid Slow Down -- Market Talk

26. sept 2025, 16:26 UTC

Tulu

Correction to Sherwin-Williams Extends Losses. What's Ailing the Paint Maker. -- Barrons.com

26. sept 2025, 16:20 UTC

Market Talk

Basic Materials Roundup: Market Talk

Võrdlus sarnastega

Hinnamuutus

Savara Inc Prognoos

Hinnasiht

By TipRanks

150.85% tõus

12 kuu keskmine prognoos

Keskmine 8.83 USD 150.85%

Kõrge 16 USD

Madal 2 USD

Põhineb 6 Wall Streeti analüütiku instrumendi Savara Inc 12 kuu hinnasihil - viimase 3 kuu andmed.

Hinnangu Konsensus

By TipRanks

Tugev "osta" hinnang

6 ratings

Osta

Hoia

Müü

Põhineb 6 analüütiku instrumendi Savara Inc aktsia reitingul - viimase 3 kuu andmed.

Tehniline skoor

By Trading Central

2.76 / 2.84Toetus ja vastupanu

The bullish and bearish events are balanced.

All events are bullish.

Bullish events outweigh bearish events.

Sentiment

By Acuity

347 / 371 Pingereas Tervishoid

Finantsandmed

Müügi- ja halduskulud

Tegevuskulud

Maksueelne kasum

Müük

Müügikulu

Brutokasum müügist

Intressikulud võla pealt

EBITDA

Ärikasum

Ettevõttest Savara Inc

Savara Inc., a clinical stage biopharmaceutical company, focuses on rare respiratory diseases. The company's lead product candidate is molgramostim, an inhaled granulocyte-macrophage colony-stimulating factor, which is in Phase 3 development stage for the treatment of autoimmune pulmonary alveolar proteinosis. Savara Inc. is headquartered in Langhorne, Pennsylvania.